Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Fluticasone Propionate vs Budesonide in Severe Persistent Asthma
NCT01687283Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2012
- Primary completion
- Nov 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate nasal spray in asthma, sponsored by GSK. Started Sep 2012; status: completed.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01687283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01687283.